Nonetheless, when considering genes that may encode novel therapeutic targets of both tumour insulin-expressing cell populations, the small number of genes ubiquitously expressed and upregulated in both clusters included COX7A2L (also known as COX7RP and SCAF1), with a mean 27-fold upregulation. This evidence concerns the gene SCAF1 and neoplasm.